BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18365874)

  • 1. Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor.
    Bermudez Y; Yang H; Cheng JQ; Kruk PA
    Growth Factors; 2008 Feb; 26(1):1-11. PubMed ID: 18365874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
    Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
    Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.
    Maida Y; Kyo S; Kanaya T; Wang Z; Yatabe N; Tanaka M; Nakamura M; Ohmichi M; Gotoh N; Murakami S; Inoue M
    Oncogene; 2002 Jun; 21(26):4071-9. PubMed ID: 12037663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
    Lössner D; Abou-Ajram C; Benge A; Reuning U
    Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
    Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
    Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
    Chang JT; Yang HT; Wang TC; Cheng AJ
    Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
    Xu K; Shu HK
    Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor increases claudin-4 expression mediated by Sp1 elevation in MDCK cells.
    Ikari A; Atomi K; Takiguchi A; Yamazaki Y; Miwa M; Sugatani J
    Biochem Biophys Res Commun; 2009 Jul; 384(3):306-10. PubMed ID: 19409881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
    Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
    Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
    Liao CH; Hsiao YM; Hsu CP; Lin MY; Wang JC; Huang YL; Ko JL
    Mol Carcinog; 2006 Apr; 45(4):220-9. PubMed ID: 16402390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of telomerase activity in malignant glioma cells by p27KIP1.
    Kanzawa T; Komata T; Kyo S; Germano IM; Kondo Y; Kondo S
    Int J Oncol; 2003 Dec; 23(6):1703-8. PubMed ID: 14612944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent.
    Bermudez Y; Yang H; Saunders BO; Cheng JQ; Nicosia SV; Kruk PA
    Gynecol Oncol; 2007 Sep; 106(3):526-37. PubMed ID: 17559911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pectenotoxin-2 represses telomerase activity in human leukemia cells through suppression of hTERT gene expression and Akt-dependent hTERT phosphorylation.
    Kim MO; Moon DO; Kang SH; Heo MS; Choi YH; Jung JH; Lee JD; Kim GY
    FEBS Lett; 2008 Oct; 582(23-24):3263-9. PubMed ID: 18775701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells.
    Liu L; Liu C; Lou F; Zhang G; Wang X; Fan Y; Yan K; Wang K; Xu Z; Hu S; Björkholm M; Xu D
    J Pathol; 2011 Oct; 225(2):203-11. PubMed ID: 21590772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA.
    Jalink M; Ge Z; Liu C; Björkholm M; Gruber A; Xu D
    Biochem Biophys Res Commun; 2007 Feb; 353(4):999-1003. PubMed ID: 17204238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct activation of TERT transcription by c-MYC.
    Wu KJ; Grandori C; Amacker M; Simon-Vermot N; Polack A; Lingner J; Dalla-Favera R
    Nat Genet; 1999 Feb; 21(2):220-4. PubMed ID: 9988278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
    Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
    Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.